Home» Circulars» Viewcirculars Back
India – Brazil synergies in Pharmaceuticals - Webinar & B2B meetings


PXL/HO/Cir-095/2020-21                                                                         Date: 09.11.2020




Dear Sir/Madam,


Subject: India – Brazil synergies in Pharmaceuticals - Webinar & B2B meetings


We are glad to inform,  Pharmexcil in  association with  Embassy of India, Brazil is organizing a virtual conference/interactive session with ANVISA officials  followed by B2B meetings with Brazil industries on 26th Nov 20.


Brazil is the largest export destination in LAC for Indian pharma despite a stringent regulatory process. The market is expected to see rising demand for Indian API and flexible guidelines and faster regulatory approvals by ANVISA to meet the requirements of essential drugs and pharmaceuticals in the country.


Program details are as follows:


“ India – Brazil Synergies in Pharmaceuticals ” 

Date: 26th November 2020

Time: 06:30 PM – 09:00 PM (IST)

Click below to Register Online.


Register for webinar

Register for B2B (one to one meetings)


Members are requested to make use of this opportunity to interact with ANVISA officials and to have business meetings. (API exporters are specially advised to actively participate in the scheduled program keeping in view of rising demand for API).


Interested member companies are requested to confirm their participation latest by 13th November 2020.  There is no participation fee to join webinar / B2B meetings. For any further information/ clarification required, you may write to rodelhi@pharmexcil.com  or contact Mr. Kumar Siddhartha at +91-9654438137.



Best Regards,



Uday Bhaskar

Director General